Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Quantum BioPharma Ltd. QNTM

Full chart Compare
Set alert

Price alert · QNTM

All alert types
2.11 USD -0.10 (-4.52%)

At closeNov 6, 2026, 8:43 AM EST

2.10 -0.01 -0.47%

Pre-market · Nov 6, 8:43 AM ET

2.06 Day range 2.20
2.06 52-week range 12.42
YTD
-71.10%
1 year
-76.56%

Financial health

Altman Z-Score

-25.36 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -0.9×
FY 2016: -3874×FY 2017: -40.5×FY 2018: -15.2×FY 2019: -1.0×FY 2020: -0.6×FY 2021: -1.0×FY 2022: -1.3×FY 2023: -2.0×FY 2024: -0.3×FY 2025: -0.9×
FY 2016 5y median -1.0× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 5501×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.5×
FY 2016: -2090×FY 2017: 11.5×FY 2018: 6.8×FY 2019: 1.1×FY 2020: 0.5×FY 2021: 0.7×FY 2022: 1.0×FY 2023: 2.8×FY 2024: 0.4×FY 2025: 3.5×
FY 2016 5y median 1.0× FY 2025
P/FCF -2.9×
FY 2016: -4166×FY 2017: -18.3×FY 2018: -15.4×FY 2019: -2.7×FY 2020: -1.0×FY 2021: -1.7×FY 2022: -1.1×FY 2023: -3.4×FY 2024: -0.6×FY 2025: -2.9×
FY 2016 5y median -1.7× FY 2025
EV/EBITDA -0.9×
FY 2016: -3830×FY 2017: -39.1×FY 2018: -14.4×FY 2019: -1.1×FY 2020: -0.1×FY 2021: -0.0×FY 2022: -0.6×FY 2023: -2.2×FY 2024: 0.1×FY 2025: -0.9×
FY 2016 5y median -0.6× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 5318×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -34.9%
FY 2016: -0.0%FY 2017: -5.5%FY 2018: -6.5%FY 2019: -36.6%FY 2020: -101.8%FY 2021: -59.6%FY 2022: -94.0%FY 2023: -29.7%FY 2024: -164.4%FY 2025: -34.9%
FY 2016 5y median -59.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: -13586.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: -13586.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -378.7%
FY 2016: 54.6%FY 2017: -28.4%FY 2018: -60.4%FY 2019: -107.9%FY 2020: -87.6%FY 2021: -65.2%FY 2022: -77.3%FY 2023: -135.2%FY 2024: -123.7%FY 2025: -378.7%
FY 2016 5y median -123.7% FY 2025
ROIC -219.7%
FY 2016: 0.0%FY 2017: -28.4%FY 2018: 0.0%FY 2019: -80.8%FY 2020: -83.4%FY 2021: -61.7%FY 2022: -88.3%FY 2023: -179.6%FY 2024: -143.2%FY 2025: -219.7%
FY 2016 5y median -143.2% FY 2025
ROA -235.0%
FY 2016: -415.1%FY 2017: -25.8%FY 2018: -58.4%FY 2019: -90.5%FY 2020: -75.8%FY 2021: -56.0%FY 2022: -61.5%FY 2023: -102.4%FY 2024: -83.0%FY 2025: -235.0%
FY 2016 5y median -83.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 5.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: -0.4%FY 2021: -9.9%FY 2022: 18.7%FY 2023: 13.3%FY 2024: 32.2%FY 2025: 5.2%
FY 2016 FY 2025
EPS (diluted) 35.1%
FY 2016: 9.4%FY 2017: -9469.0%FY 2018: -561.4%FY 2019: -96.4%FY 2020: 52.4%FY 2021: 61.8%FY 2022: 39.6%FY 2023: 25.8%FY 2024: 57.5%FY 2025: 35.1%
FY 2016 FY 2025
Free Cash Flow -21.9%
FY 2016: -42838.4%FY 2017: -22682.3%FY 2018: -166.5%FY 2019: 15.3%FY 2020: -36.6%FY 2021: -11.1%FY 2022: -35.1%FY 2023: 62.3%FY 2024: 36.5%FY 2025: -21.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 0.1×FY 2017: 4.3×FY 2018: 12.9×FY 2019: 1.3×FY 2020: 4.8×FY 2021: 5.3×FY 2022: 2.3×FY 2023: 2.4×FY 2024: 1.8×FY 2025: 1.1×
FY 2016 5y median 2.3× FY 2025
Quick Ratio 1.1×
FY 2016: 0.1×FY 2017: 4.3×FY 2018: 12.9×FY 2019: 1.1×FY 2020: 4.8×FY 2021: 5.3×FY 2022: 2.3×FY 2023: 2.4×FY 2024: 1.8×FY 2025: 1.1×
FY 2016 5y median 2.3× FY 2025
Debt / Equity 0.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.3×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 0.2×FY 2017: 1.3×FY 2018: 0.9×FY 2019: 0.1×FY 2020: 0.7×FY 2021: 1.2×FY 2022: 0.7×FY 2023: 0.2×FY 2024: 0.4×FY 2025: 0.0×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -24.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -197×FY 2020: -130×FY 2021: -486×FY 2022: -562×FY 2023: -79564×FY 2024: -339×FY 2025: -24.7×
FY 2016 5y median -486× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31